Cargando…
Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines
Cisplatin is a highly-effective and widely-used chemotherapeutic agent that causes ototoxicity in many patients. Pharmacogenomic studies of key genes controlling drug biotransformation identified variants in thiopurine methyltransferase (TPMT) as predictors of cisplatin-induced ototoxicity, although...
Autores principales: | Bhavsar, Amit P., Gunaretnam, Erandika P., Li, Yuling, Hasbullah, Jafar S., Carleton, Bruce C., Ross, Colin J. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391095/ https://www.ncbi.nlm.nih.gov/pubmed/28406961 http://dx.doi.org/10.1371/journal.pone.0175711 |
Ejemplares similares
-
All-trans retinoic acid (ATRA) regulates key genes in the RARG-TOP2B pathway and reduces anthracycline-induced cardiotoxicity
por: Hasbullah, Jafar S., et al.
Publicado: (2022) -
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicity
por: Scott, Erika N., et al.
Publicado: (2021) -
Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
por: Pussegoda, K, et al.
Publicado: (2013) -
Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?
por: Jelovac, Marina, et al.
Publicado: (2023) -
In Vitro Protein Stability of Two Naturally Occurring
Thiopurine S-Methyltransferase Variants: Biophysical Characterization
of TPMT*6 and TPMT*8
por: Wennerstrand, Patricia, et al.
Publicado: (2017)